139 related articles for article (PubMed ID: 23078763)
1. Is selective lymphadenectomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer?
Clements AE; Tierney BJ; Cohn DE; Straughn JM
Gynecol Oncol; 2013 Feb; 128(2):166-70. PubMed ID: 23078763
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Cohn DE; Huh WK; Fowler JM; Straughn JM
Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of selective lymphadenectomy based on a preoperative prediction model in patients with endometrial cancer: insights from the US and Korean healthcare systems.
Lee JY; Cohn DE; Kim Y; Lee TJ; Barnett JC; Kim JW; Jeon YW; Kim K; Park SM; Kang S
Gynecol Oncol; 2014 Dec; 135(3):518-24. PubMed ID: 25450150
[TBL] [Abstract][Full Text] [Related]
4. Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis.
Suidan RS; Sun CC; Cantor SB; Mariani A; Soliman PT; Westin SN; Lu KH; Giordano SH; Meyer LA
Obstet Gynecol; 2018 Jul; 132(1):52-58. PubMed ID: 29889752
[TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer.
Dowdy SC; Borah BJ; Bakkum-Gamez JN; Weaver AL; McGree ME; Haas LR; Keeney GL; Mariani A; Podratz KC
Gynecol Oncol; 2012 Oct; 127(1):5-10. PubMed ID: 22771890
[TBL] [Abstract][Full Text] [Related]
6. Treatment for early endometrial cancer. Cost-effectiveness analysis.
Fanning J
J Reprod Med; 1999 Aug; 44(8):719-23. PubMed ID: 10483543
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis.
McCann GA; Cohn DE; Jewell EL; Havrilesky LJ
Gynecol Oncol; 2015 Feb; 136(2):300-4. PubMed ID: 25478927
[TBL] [Abstract][Full Text] [Related]
8. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of a test to detect metastases for endometrial cancer.
Havrilesky LJ; Maxwell GL; Chan JK; Myers ER
Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.
Rankins NC; Secord AA; Jewell E; Havrilesky LJ; Soper JT; Myers E
Gynecol Oncol; 2007 Aug; 106(2):388-93. PubMed ID: 17509672
[TBL] [Abstract][Full Text] [Related]
11. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.
Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS
Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.
Fanning J; Hoffman ML; Andrews SJ; Harrah AW; Feldmeier JJ
Gynecol Oncol; 2004 Jun; 93(3):632-6. PubMed ID: 15196856
[TBL] [Abstract][Full Text] [Related]
13. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer.
Zuurendonk LD; Smit RA; Mol BW; Feijen HW; de Graaff J; Sykora D; de Winter KA; vd Wurff A; Snijders MP; Kruitwagen RF
Eur J Surg Oncol; 2006 May; 32(4):450-4. PubMed ID: 16546343
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
[TBL] [Abstract][Full Text] [Related]
15. Combined use of endometrial sample and magnetic resonance imaging in the preoperative risk-stratification of endometrial carcinomas.
Luomaranta A; Bützow R; Pauna AR; Leminen A; Loukovaara M
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):95-101. PubMed ID: 25287060
[TBL] [Abstract][Full Text] [Related]
16. Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma.
Convery PA; Cantrell LA; Di Santo N; Broadwater G; Modesitt SC; Secord AA; Havrilesky LJ
Gynecol Oncol; 2011 Oct; 123(1):65-70. PubMed ID: 21742369
[TBL] [Abstract][Full Text] [Related]
17. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness analysis of three approaches for lymph node assessment in patients with low- and intermediate-risk endometrial cancer.
Burg LC; Vermeulen RJ; Bekkers RLM; Wijn SRW; Rovers MM; Govers TM; Zusterzeel PLM
Gynecol Oncol; 2021 Apr; 161(1):251-260. PubMed ID: 33581847
[TBL] [Abstract][Full Text] [Related]
19. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
[TBL] [Abstract][Full Text] [Related]
20. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
